查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1955095

全球肺功能檢測系統市場：市場規模、佔有率、成長率、行業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034 年）

Pulmonary Function Testing Systems Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 108 Pages | 商品交期: 請詢問到貨日

價格

肺功能檢測 (PFT) 系統市場成長驅動因子

由於慢性呼吸系統疾病盛行率的上升以及診斷設備的技術進步，預計全球肺功能檢測 (PFT) 系統市場在預測期內將穩定成長。肺功能檢測系統是用於執行各種呼吸評估的專用儀器，包括肺活量測定、肺容量測量、肺容積描記法、彌散能力測量和氮氣清除試驗。 這些系統對於診斷和治療氣喘、慢性阻塞性肺病 (COPD) 和肺癌等呼吸道疾病至關重要。

市場規模及預測

2025年全球肺功能檢測系統市場規模為1.712億美元，預計2026年將成長至1.7868億美元。 預計到2034年，該市場規模將達到2.6138億美元，2026年至2034年的複合年增長率 (CAGR) 為4.87%。 2025年，北美以41.60%的市佔率領先，其中美國占主導地位。在美國，人們對早期診斷意識的提高以及肺功能檢測系統的不斷進步正在推動市場成長。預計到2032年，光是美國市場規模就將達到9,010萬美元，反映出全片幅和便攜式肺功能檢測系統均呈現強勁的普及趨勢。

市場驅動因素

肺功能檢測系統市場成長的主要驅動因素如下：

  • 發展中地區呼吸道疾病（尤其是慢性阻塞性肺病、氣喘和職業性肺病）盛行率不斷上升。根據2022年全球氣喘報告，印度約有3,500萬人患有氣喘，凸顯了早期診斷和監測的迫切性。
  • 醫護人員和病人對早期診斷的認識不斷提高。肺功能檢測系統能夠及早發現無症狀個體的肺功能障礙，以達到及時治療。
  • 技術進步，包括便攜式肺功能檢測系統。這些系統在診所和分散式醫療機構的應用日益廣泛。

新冠疫情的影響

由於醫療機構准入限制以及對檢測過程中病毒傳播的擔憂，新冠疫情暫時阻礙了市場發展。 根據加拿大胸腔科協會 (CTS) 的說法，肺功能測試已恢復，但僅限於 COVID-19 檢測結果為陰性的患者。疫情過後，市場於 2022 年開始復甦，隨著正常營運的恢復，需求穩定成長。

市場限制因子

儘管市場成長，仍面臨以下挑戰：

  • 交叉感染風險：肺功能測試使用口含器、閥門和導管，這些設備可能傳播結核病等傳染病。
  • 熟練醫護人員短缺，尤其是在開發中國家。例如，在印度，受過訓練的醫護人員數量低於每萬人 22.8 人的建議標準，限制了肺功能測試的有效實施。

市場區隔

依類型：

  • 到 2026 年，完整系統將主導市場，達到 1.0547 億美元，市場佔有率達 59.03%，這主要得益於醫院採用該系統進行全面的呼吸系統評估。
  • 由於診所和獨立診斷中心使用量的增加，以及人們對空氣污染日益關注，便攜式系統預計將實現最快增長。

依最終用戶：

  • 到 2026 年，醫院將佔最大市場佔有率，達到 9,532 萬美元（53.35%）。這主要歸因於人口老化加劇以及尋求治療的氣喘和慢性阻塞性肺病 (COPD) 患者數量增加。
  • 由於便攜式系統的普及，預計醫生集團將以最高的複合年增長率成長。
  • 此外，由於人們對肺部健康的認識不斷提高以及早期診斷的努力，諮詢和診斷中心發揮著至關重要的作用。

區域洞察

  • 北美市場預計將在2025年以7,117萬美元的規模引領市場，主要得益於肺功能檢測（PFT）系統的高普及率以及呼吸系統疾病的增加。預計到2026年，美國市場規模將達到6,850萬美元。
  • 在歐洲，醫療基礎設施的改善以及慢性阻塞性肺病（COPD）和氣喘患者的增加是推動市場發展的利多因素，預計到2026年，英國市場規模將達到700萬美元，德國將達到1120萬美元。
  • 由於宣傳活動的開展和醫療基礎設施的改善，亞太地區預計將擁有最高的複合年增長率（CAGR）。預計2026年，日本市場規模將達到1,150萬美元，中國將達到1,450萬美元，印度將達到500萬美元。 由於醫療基礎設施投資增加以及肺功能檢測需求不斷增長，拉丁美洲和中東及非洲地區正經歷穩定成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要產業趨勢：併購、商業聯盟等
  • 氣喘和慢性阻塞性肺病發病率和盛行率：依主要國家和地區劃分（2025 年）
  • 定價：依主要產品/主要公司劃分（2025 年）
  • 新冠疫情的影響市場

第五章 全球肺功能測試系統市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • 便攜式
    • 全功能型
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院
    • 諮詢（診斷）中心
    • 醫生集團（診所）
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美肺功能測試系統市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲肺功能測試系統市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第八章 亞太地區肺功能測試系統市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 其他亞洲國家太平洋

第九章 拉丁美洲肺功能偵測系統市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家/地區

第十章 中東與非洲肺功能檢測系統市場分析：洞察與預測（2021-2034）

  • 國家細分
    • 南非
    • 海灣合作委員會
    • 其他中東和非洲國家/地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • ndd Medizintechnik AG
    • COSMED srl
    • MGC Diagnostics Corporation
    • Morgan Scientific
    • CHEST M.I., Inc.
    • VYAIRE MEDICAL, INC.
    • KoKo PFT
    • Medical Electronic Construction
Product Code: FBI101158

Growth Factors of pulmonary function testing (PFT) system Market

The global pulmonary function testing (PFT) system market is projected to grow steadily over the forecast period due to the rising prevalence of chronic respiratory diseases and technological advancements in diagnostic devices. Pulmonary function testing systems are specialized devices used to perform various respiratory assessments, including spirometry, lung volumes, plethysmography, diffusion capacity, and nitrogen washout tests. These systems are critical in diagnosing and managing respiratory disorders such as asthma, COPD, and lung cancer.

Market Size & Forecast

The global pulmonary function testing system market was valued at USD 171.2 million in 2025, expected to grow to USD 178.68 million in 2026, and is projected to reach USD 261.38 million by 2034, with a CAGR of 4.87% from 2026 to 2034. North America dominated the market in 2025 with a 41.60% share, led by the U.S., where rising awareness about early diagnosis and continuous advancements in PFT systems drive market growth. The U.S. market alone is projected to reach USD 90.1 million by 2032, reflecting strong adoption of both complete and portable PFT systems.

Market Drivers

The growth of the PFT system market is primarily driven by:

  • Increasing prevalence of respiratory diseases, such as COPD, asthma, and occupational lung disorders, particularly in developing regions. According to the Global Asthma Report 2022, approximately 35 million people in India suffer from asthma, highlighting the urgent need for early diagnosis and monitoring.
  • Rising awareness of early diagnosis among healthcare providers and patients. PFT systems allow early detection of lung dysfunction in asymptomatic individuals, enabling timely treatment.
  • Technological advancements including portable PFT systems, which are increasingly used in clinics and decentralized healthcare facilities.

COVID-19 Impact

The COVID-19 pandemic temporarily hindered the market due to limited access to healthcare facilities and concerns about virus transmission during testing. According to the Canadian Thoracic Society (CTS), pulmonary function tests resumed only for patients with negative COVID-19 status. Post-pandemic, market recovery began in 2022, with demand steadily increasing as normal operations resumed.

Market Restraints

Despite growth, the market faces challenges, including:

  • Risk of cross-contamination, as PFT procedures involve mouthpieces, valves, and tubing, which can transmit infections like tuberculosis.
  • Shortage of skilled healthcare professionals, especially in developing countries. For instance, in India, the trained healthcare workforce falls below the recommended 22.8 skilled workers per 10,000 population, limiting effective adoption.

Market Segmentation

By Type:

  • Complete systems dominated the market in 2026, reaching USD 105.47 million with a 59.03% share, driven by hospital adoption for comprehensive respiratory assessments.
  • Portable systems are expected to exhibit the fastest growth due to increased use in clinics, independent diagnostic centers, and rising air pollution concerns.

By End-User:

  • Hospitals held the largest share in 2026 at USD 95.32 million (53.35%), fueled by the growing geriatric population and increased patient visits for asthma and COPD.
  • Physician clinics are projected to grow at the highest CAGR, supported by the adoption of portable systems.
  • Physical examination/diagnostic centers also play a crucial role due to increased awareness of lung health and early diagnosis initiatives.

Regional Insights

  • North America led the market with a valuation of USD 71.17 million in 2025, driven by high adoption of PFT systems and a growing prevalence of respiratory diseases. The U.S. market is projected at USD 68.5 million by 2026.
  • Europe benefits from improved healthcare infrastructure and rising cases of COPD and asthma, with the UK at USD 7 million and Germany at USD 11.2 million by 2026.
  • Asia Pacific is expected to witness the highest CAGR, propelled by awareness campaigns and healthcare infrastructure improvements. The Japan market is projected at USD 11.5 million, China at USD 14.5 million, and India at USD 5 million by 2026.
  • Latin America and Middle East & Africa are growing steadily due to investments in healthcare infrastructure and rising demand for lung function testing.

Competitive Landscape

The market is consolidated with major players such as VYAIRE MEDICAL, INC., MGC Diagnostics Corporation, PulmOne Advanced Medical Devices, ndd Medizintechnik AG, KoKo PFT, and CHEST M.I., Inc.. Companies are focusing on product launches, partnerships, and geographic expansion. Key developments include:

  • March 2023: Vitalograph launched the VitaloPFT Pulmonary Function Testing Series and partnered with Morgan Scientific to integrate advanced software with hardware.
  • January 2023: CAIRE Inc. acquired MGC Diagnostics Corporation to strengthen its pulmonary disease expertise.

Market Trends

  • Shift from complete to portable systems in clinics and decentralized healthcare settings.
  • Rising adoption of PFT systems for early diagnosis and preventive care.
  • Increasing investments by healthcare providers in technologically advanced diagnostic systems.

Conclusion

The global pulmonary function testing system market is projected to grow from USD 171.2 million in 2025 to USD 261.38 million by 2034, driven by increasing prevalence of chronic respiratory diseases, advancements in portable and complete systems, and rising awareness of early diagnosis. North America dominates the market, while Asia Pacific is emerging as the fastest-growing region. The market presents opportunities for key players through innovation, expansion into developing countries, and partnerships with healthcare providers.

Segmentation By Type

  • Portable
  • Complete

By End-user

  • Hospitals
  • Physical Examination (Diagnostic) Centers
  • Physician Groups (Clinics)
  • Others

By Region

  • North America (By Type, By End-user, By Country)
    • U.S.
    • Canada
  • Europe (By Type, By End-user, By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Type, By End-user, By Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, By End-user, By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By End-user, By Country/Sub-region)
    • South Africa
    • GCC
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments (Mergers, Acquisitions, Partnerships)
  • 4.2. Incidence and Prevalence of Asthma and COPD, Key Countries/ Region, 2025
  • 4.3. Pricing, Key Products / Key Players, 2025
  • 4.4. Impact of COVID-19 on the Market

5. Global Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Portable
    • 5.1.2. Complete
  • 5.2. Market Analysis, Insights and Forecast - By End-user
    • 5.2.1. Hospitals
    • 5.2.2. Physical Examination (Diagnostic) Centers
    • 5.2.3. Physician Groups (Clinics)
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Portable
    • 6.1.2. Complete
  • 6.2. Market Analysis, Insights and Forecast - By End-user
    • 6.2.1. Hospitals
    • 6.2.2. Physical Examination (Diagnostic) Centers
    • 6.2.3. Physician Groups (Clinics)
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Portable
    • 7.1.2. Complete
  • 7.2. Market Analysis, Insights and Forecast - By End-user
    • 7.2.1. Hospitals
    • 7.2.2. Physical Examination (Diagnostic) Centers
    • 7.2.3. Physician Groups (Clinics)
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Rest of Europe

8. Asia Pacific Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Portable
    • 8.1.2. Complete
  • 8.2. Market Analysis, Insights and Forecast - By End-user
    • 8.2.1. Hospitals
    • 8.2.2. Physical Examination (Diagnostic) Centers
    • 8.2.3. Physician Groups (Clinics)
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Rest of Asia Pacific

9. Latin America Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Portable
    • 9.1.2. Complete
  • 9.2. Market Analysis, Insights and Forecast - By End-user
    • 9.2.1. Hospitals
    • 9.2.2. Physical Examination (Diagnostic) Centers
    • 9.2.3. Physician Groups (Clinics)
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Portable
    • 10.1.2. Complete
  • 10.2. Market Analysis, Insights and Forecast - By End-user
    • 10.2.1. Hospitals
    • 10.2.2. Physical Examination (Diagnostic) Centers
    • 10.2.3. Physician Groups (Clinics)
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. South Africa
    • 10.3.2. GCC
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. ndd Medizintechnik AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. COSMED srl
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. MGC Diagnostics Corporation
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Morgan Scientific
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. CHEST M.I., Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. VYAIRE MEDICAL, INC.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. KoKo PFT
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Medical Electronic Construction
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 2: Global Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 3: Global Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 4: North America Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 5: North America Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 6: North America Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 7: Europe Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 8: Europe Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 9: Europe Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 11: Asia Pacific Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Asia Pacific Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 14: Latin America Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 15: Latin America Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 17: Middle East & Africa Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 18: Middle East & Africa Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Pulmonary Function Testing System Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Pulmonary Function Testing System Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Pulmonary Function Testing System Market Value Share (%), by End-user, 2025 & 2034
  • Figure 4: Global Pulmonary Function Testing System Market Value (USD million), by Region, 2025 & 2034
  • Figure 5: North America Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 6: North America Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 7: North America Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 8: North America Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 9: North America Pulmonary Function Testing System Market Value (USD million), By Country, 2025 & 2034
  • Figure 10: North America Pulmonary Function Testing System Market Value Share (%), By Country, 2025
  • Figure 11: Europe Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 12: Europe Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 13: Europe Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 14: Europe Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 15: Europe Pulmonary Function Testing System Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Pulmonary Function Testing System Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 18: Asia Pacific Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 19: Asia Pacific Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 20: Asia Pacific Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 21: Asia Pacific Pulmonary Function Testing System Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Pulmonary Function Testing System Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 24: Latin America Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 25: Latin America Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 26: Latin America Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 27: Latin America Pulmonary Function Testing System Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Pulmonary Function Testing System Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 30: Middle East & Africa Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 31: Middle East & Africa Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 32: Middle East & Africa Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 33: Middle East & Africa Pulmonary Function Testing System Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Pulmonary Function Testing System Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Pulmonary Function Testing System Market Share (%), By Company, 2025